- (202) 656-0791
- info@valethealthcare.com
- MON - FRI | 9:00AM - 5:00PM
Those in need of healthcare service.
Oral and Injection treatments; the clinician and patient will generate a treatment plan that best suites the patients’ needs and lifestyle.
Dec. 24, 2014 — A drug that treats type 2 diabetes has gotten FDA approval for another use: weight loss. Saxenda is the fourth drug for weight loss OK’d by the agency since 2012. It’s already available in a lower dose as Victoza for type 2 diabetes. Researchers began to study it as an obesity treatment after people on Victoza reported weight loss. Saxenda, like Victoza, is injected daily. It’s approved for people with a body mass index (BMI) of 30, considered obese, or a BMI of 27 with weight-related conditions such as high blood pressure. It’s meant to be used with exercise and a reduced calorie diet.
Our promise is to empower each patient with knowledge of health promotion & disease prevention that is holistic, culturally & ethnically competent, gender identity & age specific.
*Not accepting insurance at this time. This service will be coming soon.
In lieu of COVID-19, ValetHealth is taking extra precautions to ensure the safety of our patients and staff. We will continue to serve our patients via telemedicine. House calls remain on an as needed base only. We will keep everyone updated with any changes.